1. Home
  2. BANL vs MEIP Comparison

BANL vs MEIP Comparison

Compare BANL & MEIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BANL
  • MEIP
  • Stock Information
  • Founded
  • BANL 2015
  • MEIP 2000
  • Country
  • BANL Malaysia
  • MEIP United States
  • Employees
  • BANL N/A
  • MEIP N/A
  • Industry
  • BANL Oil Refining/Marketing
  • MEIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • BANL Energy
  • MEIP Health Care
  • Exchange
  • BANL Nasdaq
  • MEIP Nasdaq
  • Market Cap
  • BANL 17.6M
  • MEIP 19.5M
  • IPO Year
  • BANL 2023
  • MEIP 2003
  • Fundamental
  • Price
  • BANL $0.99
  • MEIP $2.78
  • Analyst Decision
  • BANL
  • MEIP Hold
  • Analyst Count
  • BANL 0
  • MEIP 2
  • Target Price
  • BANL N/A
  • MEIP $7.00
  • AVG Volume (30 Days)
  • BANL 9.8K
  • MEIP 103.7K
  • Earning Date
  • BANL 09-12-2024
  • MEIP 11-12-2024
  • Dividend Yield
  • BANL N/A
  • MEIP N/A
  • EPS Growth
  • BANL N/A
  • MEIP N/A
  • EPS
  • BANL N/A
  • MEIP N/A
  • Revenue
  • BANL $521,173,543.00
  • MEIP N/A
  • Revenue This Year
  • BANL N/A
  • MEIP N/A
  • Revenue Next Year
  • BANL N/A
  • MEIP $300.00
  • P/E Ratio
  • BANL N/A
  • MEIP N/A
  • Revenue Growth
  • BANL 24.34
  • MEIP 33.76
  • 52 Week Low
  • BANL $0.55
  • MEIP $2.61
  • 52 Week High
  • BANL $1.87
  • MEIP $6.91
  • Technical
  • Relative Strength Index (RSI)
  • BANL 49.91
  • MEIP 36.75
  • Support Level
  • BANL $0.94
  • MEIP $2.76
  • Resistance Level
  • BANL $1.01
  • MEIP $2.91
  • Average True Range (ATR)
  • BANL 0.06
  • MEIP 0.11
  • MACD
  • BANL -0.01
  • MEIP -0.04
  • Stochastic Oscillator
  • BANL 40.48
  • MEIP 5.13

About BANL CBL International Limited

CBL International Ltd is a company that provides a complete range of marine fuel logistics services. It sources the highest quality marine fuel from its trusted suppliers and ensures timely delivery to its customers. The company's expertise lies in providing a seamless and efficient one-stop solution for vessel refueling needs, making it a reliable partner for shipping companies. CBL International Ltd has a strong presence in China, Hong Kong, and Malaysia.

About MEIP MEI Pharma Inc.

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

Share on Social Networks: